Advertisement
BD Biosciences
BD Biosciences

The Scientist

» drug development

Most Recent

image: Shire to Buy Baxalta for $32 Billion

Shire to Buy Baxalta for $32 Billion

By | January 12, 2016

The Dublin-based pharma giant is set to acquire Baxalta, an Illinois-based Baxter spinoff, expanding its rare disease drug portfolio.

0 Comments

image: Picking Up the Pace

Picking Up the Pace

By | January 1, 2016

FDA designations promise to expedite the approval of drugs for conditions ranging from infectious disease to cancer.

0 Comments

image: The Age of Pharmabrewing

The Age of Pharmabrewing

By | January 1, 2016

We should not resist developing opiate-producing GM yeast for fear of the technology falling into the wrong hands.

0 Comments

image: Viral Soldiers

Viral Soldiers

By | January 1, 2016

Phage therapy to combat bacterial infections is garnering attention for the second time in 100 years, but solid clinical support for its widespread use is still lacking.

11 Comments

image: First Dengue Vax Approved

First Dengue Vax Approved

By | December 11, 2015

Mexico’s health ministry has OKed the vaccine for people between nine and 45 years old.

0 Comments

image: Another Obesity Drug Trial Death

Another Obesity Drug Trial Death

By | December 2, 2015

A second patient taking an experimental medication to treat Prader-Willi Syndrome has died of blood clots.

0 Comments

image: Fatal Disease Drug in Limbo

Fatal Disease Drug in Limbo

By | November 25, 2015

A panel of experts advised the US Food and Drug Administration that BioMarin Pharmaceutical has not demonstrated efficacy of its new drug for Duchenne muscular dystrophy.

0 Comments

image: Opinion: Translation Nation

Opinion: Translation Nation

By | November 18, 2015

What’s in store for commercialization grants at the Canadian Institutes of Health Research?

0 Comments

image: Clinical Trial Data Underreported: Study

Clinical Trial Data Underreported: Study

By | November 16, 2015

One-third of the human experiments for approved drugs failed transparency requirements.

0 Comments

image: Breaching the Blood-Brain Barrier

Breaching the Blood-Brain Barrier

By | November 11, 2015

Researchers deliver cancer-fighting drugs to a patient’s brain via the bloodstream, penetrating the blood-brain barrier for the first time.

0 Comments

Advertisement
Lonza
Lonza

Popular Now

  1. Antibody Alternatives
    Features Antibody Alternatives

    Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

  2. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  3. Circadian Clock and Aging
    Daily News Circadian Clock and Aging

    Whether a critical circadian clock gene is deleted before or after birth impacts the observed aging-related effects in mice.

  4. Biologist Resigns Amid Sexual Misconduct Probe
Advertisement
Advertisement
Life Technologies